Goals of Care and Advance Care Planning over Time
These modules define goals of care, adjusting conversations based on patient’s wishes and preferences, how and when to discuss hospice in a goals of care discussion, and describes the components of advance care planning based on stage of health.
Category
  • Palliative Care
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
POLST Paradigm – Physician Orders for Life Sustaining Treatment Paradigm
This module distinguishes between an advance directive and POLST forms, identifies patients who are appropriate to start a POLST discussion and how to use the POLST form to create actionable medical orders to ensure seriously ill patient’s decisions about life-sustaining treatment are respected i
Category
  • Palliative Care
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Addressing Symptoms that Impact Quality of Life: Nausea/Vomiting, Constipation, Dyspnea & Shortness of Breath
These modules describe the common causes, assessment of, and ways to manage nausea/vomiting, constipation and dyspnea/shortness of breath.
Category
  • Palliative Care
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Primary Palliative Care vs. Specialized Palliative Care and Reasons to Refer to Hospice and Palliative Care
These modules describe oncology team practices that are “primary palliative care” compared to palliative medicine specialist care, when a palliative medicine specialist may be appropriate for a patient, the difference between palliative care and hospice care programs, when a referral to hospice i
Category
  • Palliative Care
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - Bladder Cancer, Version 5.2018
The NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with bladder cancer.
Category
  • Bladder Cancer
Format
  • Monograph/Journal Supplement
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Breast Cancer
Management of HR-Sensitive, HER2-Negative Advanced Breast Cancer
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: The Evolving Landscape of Immunotherapy and Targeted Therapy for Non-Small Cell Lung Cancer
Join Sally Barbour, PharmD, BCOP, CPP, FHOPA, from Duke Cancer Institute for this webinar in the 2018 NCCN Pharmacy Update Series on the topic The Evolving Landscape of Immunotherapy and Targeted Therapy for Non-Small Cell Lung Cancer.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - Small Cell Lung Cancer, Version 2.2018
The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease management. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for SCLC regarding immunotherapy, systemic therapy, and radiation therapy.
Category
  • Lung Cancers
Format
  • Monograph/Journal Supplement
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Introduction to the NCCN Guidelines® for Vulvar Cancer and Corresponding Systemic Therapy Recommendations
Join Abby Miske, PharmD, BCOP, from Seattle Cancer Care Alliance for this webinar in the 2018 NCCN Pharmacy Update Series on the topic Introduction to the NCCN Guidelines® for Vulvar Cancer and Corresponding Systemic Therapy Recommendations.
Category
  • Women's Health Cancers
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Keynote Session: CAR T-cell Therapy - Focus on Lymphomas
Chimeric antigen receptor (CAR) T-cell therapy is a new and rapidly evolving immunotherapy emerging as a novel treatment option for relapsed or refractory lymphomas.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages